Bibliography

Aikin, Kathryn. “The Impact of Direct-to-Consumer Prescription Drug Advertising on

            the Physician-Patient Relationship.” FDA, 2003.

            http://www.fda.gov/cder/ddmac/aikin.

Beardsley, Sara. “Avoiding Another Vioxx.” Scientific America . 292 (Feb 2005) 16.

http://0-web17.epnet.com.libra.nazlib.org.

Elliot, Stuart. “With or Without Vioxx, Drug Ads Proliferate.” The New York Times.

December 6, 2004. http://0-web.lexis-nexis.com.libra.nazlib.org.

Elliot , Victoria Stagg. “FDA Survey Puts Positive Spin on Direct-to-Consumer Ads.” Amednews.com

            (Feb2003), 3. http://www.ama- assn.org/amednews/2003/02/03/hlsb0203.htm.  

Kolata, Gina. “A Widely Used Arthritis Drug Is Withdrawn.” The New York Times.

             October 1, 2004, http://0-web.lexis-nexis.com.libra.nazlib.org

Mintzes, Barbara and others. “How Does DTCA affect Prescribing? A Survey in Primary

            Care Environments with and without Legal DTCA.” Canadian Medical

            Association Journal, 169 (Septmeber 2003) 1. http://0- web17.epnet.com.libra.nazlib.org.

NIHCM Foundation. “Prescription Drugs and Mass Media Advertising: 1999-2000.”

            NIHCM DTC Report, 7. www.nihcm.org/DTCbrief2001.pdf.

Nordenberg, Tamar. “Direct to You: TV Drug Ads That Make Sense.” U.S. Food and

            Drug Administration,  1998. http://www.fda.gov/fdac/features/1998/198_ads.html.                       

 Palumbo, Francis and B.C. Daniel Mullins. “The Development of Direct-to-Consumer Prescription Drug 

            Advertising Regulation.” Food and Drug Law Journal, 57 (November 3, 2002), 425.  

            http://www.kff.org/rxdrugs/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=14372

Rosenberg, Janice.  “Patient Orders: When Patients Ask for Specific Drugs.” American Medical News (March

            2001), 1. http://www.ama-assn.org/amednews/2001/03/19/hlsa0319.htm.

Senator Chuck Grassley. “Opening Statements.” Hearing—FDA Merck and Vioxx:

            Putting Patient Safety First? November 18, 2004. http://finance.senate.gov.

Sasich, Larry D. Parm.D., M.P.H. “Comments on Food and Drug Administration’s Draft

            Guidance for Industry on Direct to Consumer Advertising.” Public Citizen

            (October 1997), 2. http://www.citizen.org/publications/release.cfm?ID=6626. 

Shaw, Michael S. “The DTC Dilemma.” Ethicad, 5 http://www.ethicad.org/dilemma.pdf.

Terzian, Tamar V.  "Direct-to-Consumer Prescription Drug Advertising." American Journal of Law and

           Medicine. 25 (1999), 5.http://0-web17.epnet.com.libra.nazlib.org.

Tsao, Amy.  "Viagra: A Drug Ad Too Far?" Business Week Online. (November 17, 2004), 2.

            http://0-web17.epnet.com.libra.nazlib.org.

United States Department of Health and Human Services, Food And Drug

            Administration, Center for Devices and Radiological Health, Office of

            Compliance. “Draft Guidance for Industry and FDA: Consumer-Directed

             Broadcast Advertising of Restricted Devices.” (1997), 3.

            http://www.fda.gov/cdrh/comp/guidance/1513.pdf.

United States General Accounting Office. "FDA Oversight of Direct-to-Consumer Advertising has Limitations."

            (2002), 6. http://www.gao.gov/atext/d03177.txt.

United States General Accounting Office. “Prescription Drugs: Little is Known About the

            Effects of Direct-to Consumer Advertising.” (1991), 2.

            http://161.203.16.4/d19t9/144561.pdf.

Title Page